What changed in this filing

/stocks — the workspaceLOADING

Item 9A. Controls and Procedures

2025-08-26 compared with 2024-08-27 · 155 added, 196 removed, 21 unchanged (94% of the section changed)

and Procedures.

of Disclosure Controls and Procedures

principal executive officer and principal financial officer evaluated the effectiveness of our disclosure controls and procedures,

as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act, as of the end of the period subject to this Annual Report

on Form 10-K.

Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure

controls and procedures were effective.

Report on Internal Control over Financial Reporting

management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is

defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act.

Internal control over financial reporting refers to the process

designed by, or under the supervision of, our President and Chief Executive Officer and our Chief Financial Officer, and effected

by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial

reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles,

and includes those policies and procedures that:

Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions

of our assets;

Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance

with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorization

of our management and directors;

Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our

assets that could have a material effect on the financial statements.

of its inherent limitations, internal control over financial reporting cannot provide absolute assurance of preventing and detecting

misstatements on a timely basis.

It is possible to design into the process safeguards to reduce, though not eliminate, the risk

that misstatements are not prevented or detected on a timely basis.

Management is responsible for establishing and maintaining

adequate internal control over financial reporting for the Company.

management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework

set forth in the report entitled Internal Control-Integrated Framework published by the Committee of Sponsoring Organizations

of the Treadway Commission in 2013.

Based on this assessment, management has concluded that, as of June 30, 2024, our internal

control over financial reporting was effective.

Annual Report on Form 10-K does not include an attestation report of our independent registered public accounting firm regarding

internal control over financial reporting.

Management’s report was not subject to attestation by the Company’s independent

registered public accounting firm pursuant to the rules of the SEC that exempt smaller reporting companies from the auditor attestation

in Internal Control Over Financial Reporting

were no changes in our internal control over financial reporting that occurred during the fourth quarter of fiscal 2024 that have

materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

the three months ended June 30, 2024, no director or officer of the Company adopted, modified or terminated a “Rule

10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a)

of Regulation S-K.

Regarding Foreign Jurisdictions that Prevent Inspections.

information required by Part III is incorporated by reference from our definitive Proxy Statement for the annual meeting of shareholders

to be held in 2024 (the “Proxy Statement”).

Except for those portions specifically incorporated in this Annual Report

on Form 10-K by reference to the Proxy Statement, no other portions of the Proxy Statement are deemed to be filed as part of this

Annual Report on Form 10-K.

Executive Officers and Corporate Governance.

about our Executive Officers

following sets forth certain information about our current executive officers:

Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act that are designed to provide reasonable assurance that information required to be disclosed in our reports filed or submitted under the Exchange Act) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Our principal executive officer and principal financial officer evaluated the effectiveness of our disclosure controls and procedures as of the end of the period subject to this Annual Report on Form 10-K.

Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective.

Management ’ s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act.

Internal control over financial reporting refers to the process designed by, or under the supervision of, our President and Chief Executive Officer and our Chief Financial Officer, and effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, and includes those policies and procedures that:

(1) Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;

(2) Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorization of our management and directors;

(3) Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting cannot provide absolute assurance of preventing and detecting misstatements on a timely basis.

It is possible to design into the process safeguards to reduce, though not eliminate, the risk that misstatements are not prevented or detected on a timely basis.

Management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company.

Our management conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework set forth in the report entitled Internal Control-Integrated Framework published by the Committee of Sponsoring Organizations of the Treadway Commission in 2013.

Based on this assessment, management has concluded that, as of June 30, 2025, our internal control over financial reporting was effective.

This Annual Report on Form 10-K does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting.

Management’s report was not subject to attestation by the Company’s independent registered public accounting firm pursuant to the rules of the SEC that exempt smaller reporting companies from the auditor attestation requirement.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the fourth quarter of fiscal 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Other Information.

During the three months ended June 30, 2025 , no director or officer of the Company adopted, modified or terminated a “Rule 10b5 - 1 trading arrangement” or “non-Rule 10b5 - 1 trading arrangement,” as each term is defined in Item 408 (a) of Regulation S-K.

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

Not applicable.

Certain information required by Part III is incorporated by reference from our definitive Proxy Statement for the annual meeting of shareholders to be held in 2025 (the “Proxy Statement”).

Except for those portions specifically incorporated in this Annual Report on Form 10-K by reference to the Proxy Statement, no other portions of the Proxy Statement are deemed to be filed as part of this Annual Report on Form 10-K.

Directors, Executive Officers and Corporate Governance.

Information about our Executive Officers

The following sets forth certain information about our current executive officers:

Cunniff , age 60, joined Electromed in July 2023 as the Company’s President and Chief Executive Officer.

joining Electromed, Mr.

Prior to joining Electromed, Mr.

Cunniff most recently served as President and Chief Executive Officer of Provista Inc., from 2017 to May 2022.

Previously, he served as President and Chief Executive Officer at Denver Solutions, LLC (d/b/a Leiters Health) from 2015

to 2017 and as Senior Vice President, Americas, at Acelity L.P.

Previously, he served as President and Chief Executive Officer at Denver Solutions, LLC (d/b/a Leiters Health) from 2015 to 2017 and as Senior Vice President, Americas, at Acelity L.P.

Inc., from 2012 to 2014.

Cunniff holds a bachelor’s

degree in advertising and business from the University of Illinois Urbana-Champaign and has completed the Advanced Management

Program at Harvard Business School.

Cunniff holds a bachelor’s degree in advertising and business from the University of Illinois Urbana-Champaign and has completed the Advanced Management Program at Harvard Business School.

Nagel , age 43, joined Electromed in November 2022 as the Company’s Chief Financial Officer, Treasurer and Secretary.

Prior to joining Electromed, Mr.

Nagel most recently served as Divisional Chief Financial Officer of Global Lung Health and Visualization

at Medtronic plc from June 2018 to November 2022.

Nagel most recently served as Divisional Chief Financial Officer of Global Lung Health and Visualization at Medtronic plc from June 2018 to November 2022.

Previously, he served at Medtronic as Sr.

Manager, Accounting and Sales Operations

from 2016 to June 2018 and Accounting Manager from 2015 to 2016.

Manager, Accounting and Sales Operations from 2016 to June 2018 and Accounting Manager from 2015 to 2016.

Before joining Medtronic, Mr.

Nagel held various roles of increasing

responsibility in sales, operations and accounting at Target Corporation and TCF Financial Corporation.

Nagel holds a bachelor’s

degree in business & finance from Calvin University.

Board annually reviews and approves revisions to our Code of Ethics and Business Conduct (the “Code of Ethics”) that

applies to all employees, directors, and officers, including the Chief Executive Officer and the Chief Financial Officer (Principal

Financial Officer and Principal Accounting Officer).

The Code of Ethics is available in the “Investor Relations” section

of our website at www.smartvest.com.

We intend to disclose on our website any amendment to or waiver from any provision of the

Code of Ethics that applies to our Chief Executive Officer or our Chief Financial Officer (Principal Financial Officer and Principal

Accounting Officer), and that relates to any element of the Code of Ethics identified in Item 406(b) of Regulation S-K, as promulgated

Nagel held various roles of increasing responsibility in sales, operations and accounting at Target Corporation and TCF Financial Corporation.

Nagel holds a bachelor’s degree in business & finance from Calvin University.

Code of Ethics

Our Board annually reviews and approves revisions to our Code of Ethics and Business Conduct (the “Code of Ethics”) that applies to all employees, directors, and officers, including the Chief Executive Officer and the Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer).

The Code of Ethics is available in the “Investor Relations” section of our website at www.smartvest.com.

We intend to disclose on our website any amendment to or waiver from any provision of the Code of Ethics that applies to our Chief Executive Officer or our Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer), and that relates to any element of the Code of Ethics identified in Item 406 (b) of Regulation S-K, as promulgated by the SEC.

Such disclosure will be provided promptly following the date of the amendment or waiver.

additional information required by this item is incorporated herein by reference to the sections labeled “Election of Directors,”

“Corporate Governance,” “and “Security Ownership Certain Beneficial Owners and Management” and,

if any, under “Delinquent Section 16(a) Reports” in the Proxy Statement.

Compensation.

information required by this item is incorporated herein by reference to the sections labeled “Executive Compensation,”

“Director Compensation,” and “Corporate Governance – Personnel and Compensation Committee” in the

Proxy Statement.

Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

information required by this item relating to the security ownership of certain holders is incorporated herein by reference to

the sections labeled “Security Ownership of Certain Beneficial Owners and Management” and “Equity Compensation

Plan Information” in the Proxy Statement.

Relationships and Related Transactions, and Director Independence.

information required by this item is incorporated herein by reference to the sections labeled “Corporate Governance–Independence”

and “Related Person Transaction Approval Policy” in the Proxy Statement.

Accountant Fees and Services.

independent registered public accounting firm is RSM US LLP, Rochester, MN

information required by this item is incorporated herein by reference to the section labeled “Ratification of the Appointment

of the Company’s Independent Registered Public Accounting Firm – Audit Fees” in the Proxy Statement.

and Financial Statement Schedules.

(a) Documents

filed as part of this report.

(1) Financial

The following financial statements are included in Part II, Item 8 of this

Annual Report on Form 10-K:

of Independent Registered Public Accounting Firm, PCAOB ID:

Sheets as of June 30, 2024 and 2023

of Operations for the years ended June 30, 2024 and 2023

of Shareholders’ Equity for the years ended June 30, 2024 and 2023

of Cash Flows for the years ended June 30, 2024 and 2023

to Financial Statements

(2) Financial

Statement Schedules.

No financial statement schedule is required to be included in this

Annual Report on Form 10-K.

Articles of Incorporation, as amended through November 8, 2010 (incorporated by reference to Exhibit 3.1 to Annual

Report on Form 10-K for the fiscal year ended June 30, 2015)

and Restated Bylaws, effective September 29, 2020 (incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K

filed September 29, 2020)

of Securities (incorporated by reference to Exhibit 4.1 to Annual Report on Form 10-K for the fiscal year ended June 30,

We are not including the information contained on our website as part of, or incorporating it by reference into, this report or any other filing or document submitted to the SEC.

The additional information required by this item is incorporated herein by reference to the sections labeled “Election of Directors,” “Corporate Governance,” “Security Holder Communications to the Board of Directors,” “Security Ownership Certain Beneficial Owners and Management” and, if any, under “Delinquent Section 16 (a) Reports” in the Proxy Statement.

Insider Trading Policy

We have adopted an Insider Training Policy governing the purchase, sale and /or other dispositions of our securities by directors, officers and employees.

Our Insider Training Policy is filed as Exhibit 19.

Executive Compensation.

The information required by this item is incorporated herein by reference to the sections labeled “Executive Compensation,” “Director Compensation,” and “Corporate Governance – Personnel and Compensation Committee” in the Proxy Statement.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The information required by this item relating to the security ownership of certain holders is incorporated herein by reference to the sections labeled “Security Ownership of Certain Beneficial Owners and Management” and “Equity Compensation Plan Information” in the Proxy Statement.

Certain Relationships and Related Transactions, and Director Independence.

The information required by this item is incorporated herein by reference to the sections labeled “Corporate Governance” and “Certain Relationships and Related-Party Transactions” in the Proxy Statement.

Principal Accountant Fees and Services.

Our independent registered public accounting firm is RSM US LLP, Minneapolis, MN.

The information required by this item is incorporated herein by reference to the subsections labeled “Audit Fees” and “Audit Committee Pre-Approval” under the “Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm” heading in the Proxy Statement.

Exhibits and Financial Statement Schedules.

Documents filed as part of this report.

Financial Statements.

The following financial statements are included in Part II, Item 8 of this Annual Report on Form 10-K:

Report of Independent Registered Public Accounting Firm, PCAOB ID:

Balance Sheets as of June 30, 2025, and 2024

Statements of Operations for the years ended June 30, 2025, and 2024

Statements of Shareholders’ Equity for the years ended June 30, 2025, and 2024

Statements of Cash Flows for the years ended June 30, 2025, and 2024

Notes to Financial Statements

Financial Statement Schedules.

No financial statement schedule is required to be included in this Annual Report on Form 10-K.

Method of Filing

Composite Articles of Incorporation, as amended through November 8, 2010 (incorporated by reference to Exhibit 3.1 to Annual Report on Form 10-K for the fiscal year ended June 30, 2015)

Incorporated by Reference

Amended and Restated Bylaws, effective November 15, 2024 (incorporated by reference to Exhibit 3.1 to Current Report on Form 8-K filed November 18, 2024).

Incorporated by Reference

Description of Securities (incorporated by reference to Exhibit 4.1 to Annual Report on Form 10-K for the fiscal year ended June 30, 2019)

Incorporated by Reference

Electromed, Inc.

2014 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed November 25, 2014)*

of Incentive Stock Option Agreement under the Electromed, Inc.

2014 Equity Incentive Plan (incorporated by reference to Exhibit 10.2

to Current Report on Form 8-K filed November 25, 2014)*

of Nonqualified Stock Option Agreement under the Electromed, Inc.

2014 Equity Incentive Plan (incorporated by reference to

Exhibit 10.3 to Current Report on Form 8-K filed November 25, 2014)*

of Restricted Stock Agreement under the Electromed, Inc.

2014 Equity Incentive Plan (incorporated by reference to Exhibit 10.4

to Current Report on Form 8-K filed November 25, 2014)*

Incorporated by Reference

Form of Nonqualified Stock Option Agreement under the Electromed, Inc.

2014 Equity Incentive Plan (incorporated by reference to Exhibit 10.3 to Current Report on Form 8-K filed November 25, 2014)*

Incorporated by Reference

Electromed, Inc.

2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 99.1 to Registration Statement on Form S-8 filed December 4, 2017)*

of Restricted Award Agreement under the 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.11 to Annual

Report on Form 10-K for the fiscal year ended June 30, 2018)*

of Non-Qualified Option Agreement under the 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to

Quarterly Report on Form 10-Q for the quarter ended March 31, 2019)*

of Restricted Stock Agreement (Non-Employee Directors) under the 2017 Omnibus Incentive Plan (incorporated by reference to

Exhibit 10.13 to Annual Report on Form 10-K for the fiscal year ended June 30, 2018)*

of Performance Stock Unit Agreement (Inducement Grant) (incorporated by reference to Exhibit 10.11 to Annual Report on Form

10-K for the fiscal year ended June 30, 2023)*

of Non-Qualified Stock Option Agreement (Inducement Grant) (incorporated by reference to Exhibit 10.12 to Annual Report on

Form 10-K for the fiscal year ended June 30, 2023)*

Agreement with Bradley M.

Nagel, dated October 19, 2022 (incorporated by reference to Exhibit 10.1 to Current Report on Form

8-K filed October 24, 2022)*

Incorporated by Reference

Agreement with Kathleen S.

Skarvan, dated February 14, 2023 (incorporated by reference to Exhibit 10.1 to Current Report on

Form 8-K filed February 14, 2023)*

Form of Restricted Award Agreement under the 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.11 to Annual Report on Form 10-K for the fiscal year ended June 30, 2018)*

Incorporated by Reference

Agreement with James Cunniff, dated May 22, 2023 (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K

filed June 5, 2023)*

Form of Non-Qualified Option Agreement under the 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to Quarterly Report on Form 10-Q for the quarter ended March 31, 2019)*

Incorporated by Reference

Agreement with James Cunniff, dated May 22, 2023 (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K

filed June 5, 2023)*

Form of Performance Stock Unit Agreement (Inducement Grant) (incorporated by reference to Exhibit 10.11 to Annual Report on Form 10-K for the fiscal year ended June 30, 2023)*

Incorporated by Reference

Loan Agreement with Choice Financial Group, dated December 18, 2019 (incorporated by reference to Exhibit 10.1 to Current

Report on Form 8-K filed December 17, 2019)

to Business Loan Agreement (Asset Based) with Choice Financial Group, dated December 18, 2019 (incorporated by reference to

Exhibit 10.2 to Current Report on Form 8-K filed December 17, 2019)

to Business Loan Agreement (Asset Based) with Choice Financial Group, dated December 16, 2020 (incorporated by reference to

Exhibit 10.2 to Current Report on Form 8-K filed December 17, 2020)

to Business Loan Agreement (Asset Based) with Choice Financial Group, dated December 17, 2021 (incorporated by reference to

Form of Non-Qualified Stock Option Agreement (Inducement Grant) (incorporated by reference to Exhibit 10.12 to Annual Report on Form 10-K for the fiscal year ended June 30, 2023)*

Incorporated by Reference

Employment Agreement with Bradley M.

Nagel, dated October 19, 2022 (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed October 24, 2022)*

Incorporated by Reference

Letter Agreement with Kathleen S.

Skarvan, dated February 14, 2023 (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed February 14, 2023)*

Incorporated by Reference

Employment Agreement with James Cunniff, dated May 22, 2023 (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed June 5, 2023)*

Incorporated by Reference

Method of Filing

Business Loan Agreement with Choice Financial Group, dated December 18, 2019 (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K filed December 17, 2019)

Incorporated by Reference

Rider to Business Loan Agreement (Asset Based) with Choice Financial Group, dated December 18, 2019 (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed December 17, 2019)

Incorporated by Reference

Rider to Business Loan Agreement (Asset Based) with Choice Financial Group, dated December 16, 2020 (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed December 17, 2020)

Incorporated by Reference

Rider to Business Loan Agreement (Asset Based) with Choice Financial Group, dated December 17, 2021 (incorporated by reference to Exhibit 10.

1 to Current Report on 8-K filed December 17, 2021)

to Business Loan Agreement (Asset Based) with Choice Financial Group, dated December 13, 2023 (incorporated by reference to

Exhibit 10.2 to Current Report on Form 8-K filed December 15, 2023)

Incorporated by Reference

Rider to Business Loan Agreement (Asset Based) with Choice Financial Group, dated December 13, 2023 (incorporated by reference to Exhibit 10.2 to Current Report on Form 8-K filed December 15, 2023)

Incorporated by Reference

Electromed, Inc.

2023 Equity Incentive Plan (incorporated by reference to Exhibit 4.3 to Registration Statement on Form S-8 filed November 30, 2023)*

of Restricted Stock Agreement (Non-Employee Directors) under the 2023 Equity Incentive Plan (incorporated by reference to

Exhibit 10.3 to Quarterly Report on Form 10-Q for the quarter ended December 31, 2023)*

of Fiscal Year 2024 Officer Bonus Plan (incorporated by reference to Exhibit 10.26 to Annual Report on Form 10-K for the fiscal

year ended June 30, 2023)*

of Fiscal Year 2025 Officer Bonus Plan*

Electronically

Trading Policy

Electronically

of Independent Registered Public Accounting Firm

Electronically

Certification

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Electronically

Certification

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Electronically

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Electronically

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Electronically

Recoupment Policy

Electronically

statements from the annual report on Form 10-K for the year ended June 30, 2024, as filed with the Securities and Exchange

Commission, formatted in inline eXtensible Business Reporting Language (iXBRL):

Incorporated by Reference

Form of Restricted Stock Agreement (Non-Employee Directors) under the 2023 Equity Incentive Plan (incorporated by reference to Exhibit 10.3 to Quarterly Report on Form 10-Q for the quarter ended December 31, 2023)*

Incorporated by Reference

Form of Non-Qualified Stock Option Agreement under the 2023 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to Quarterly Report on Form 10-Q filed November 12, 2024)*

Incorporated by Reference

Form of Restricted Stock Agreement (Employees) under the 2023 Equity Incentive Plan (incorporated by reference to Exhibit 10.2 to Quarterly Report on Form 10-Q filed November 12, 2024)*

Incorporated by Reference

Description of Fiscal Year 2025 Officer Bonus Plan (incorporated by reference to Exhibit 10.23 to Annual Report on Form 10-K for the fiscal year ended June 30, 2024)*

Incorporated by Reference

Description of Fiscal Year 2026 Officer Bonus Plan*

Filed Electronically

Insider Trading Policy (incorporated by reference to Exhibit 19 to Annual Report on Form 10-K for the fiscal year ended June 30, 2024)

Incorporated by Reference

Consent of Independent Registered Public Accounting Firm

Filed Electronically

Powers of Attorney

Filed Electronically

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Filed Electronically

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Filed Electronically

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Furnished Electronically

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Furnished Electronically

Compensation Recoupment Policy (incorporated by reference to Exhibit 97 to Annual Report on Form 10-K for the fiscal year ended June 30, 2024)

Incorporated by Reference

Financial statements from the annual report on Form 10-K for the year ended June 30, 2025, as filed with the Securities and Exchange Commission, formatted in inline eXtensible Business Reporting Language (iXBRL):

(i) Balance Sheets;

(ii) Statements of Operations,

(iii) Statements of Shareholders’ Equity, (iv) Statements of Cash Flows, and (v) Notes to Financial Statements

Electronically

Page Interactive Data File (embedded within the inline XBRL Document)

electronically

compensatory contract or arrangement.

10-K Summary.

to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report

to be signed on its behalf by the undersigned, thereunto duly authorized.

(ii) Statements of Operations, (iii) Statements of Shareholders’ Equity, (iv) Statements of Cash Flows, (v) Notes to Financial Statements, and (vi) the information set forth in Part II, Item 9B.

Filed Electronically

Cover Page Interactive Data File (embedded within the inline XBRL Document)

Filed electronically

Management compensatory contract or arrangement.

Form 10-K Summary.

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ELECTROMED, INC.

1 unchanged sentence

President and Chief Executive Officer

to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf

of the registrant and in the capacities and on the dates indicated.

and Chief Executive Officer and Director

executive officer)

Financial Officer

financial and accounting officer)

undersigned, by signing his name hereto, does hereby sign this document on behalf of

each of the above-named directors of the registrant pursuant to powers of attorney duly

executed by such persons.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

President and Chief Executive Officer and Director

August 26, 2025

(principal executive officer)

/s/ Bradley M.

Chief Financial Officer

August 26, 2025

(principal financial and accounting officer)

August 26, 2025

The undersigned, by signing his name hereto, does hereby sign this document on behalf of each of the above-named directors of the registrant pursuant to powers of attorney duly executed by such persons.

Attorney-in-Fact

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 9A. Controls and Procedures